Readnour Robin Shane
SEC insider (Form 3/4/5 filer). CIK 0001914883. Director at AN2 Therapeutics, Inc. (ANTX). 29 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2026. Located in MENLO PARK, CA.
Companies Readnour Robin Shane has filed insider reports for
- AN2 Therapeutics, Inc. (ANTX): Director
Readnour Robin Shane
CIK: 0001914883
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AN2 Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Sep 9, 2026ANTX
AN2 Therapeutics, Inc.
SaleIndirect523 shares at avg. $6.02$3K - Sep 9, 2026ANTX
AN2 Therapeutics, Inc.
SaleIndirect585 shares at avg. $6.02$4K - Sep 8, 2026ANTX
AN2 Therapeutics, Inc.
SaleIndirect5.3K shares at avg. $6.02$32K - Sep 8, 2026ANTX
AN2 Therapeutics, Inc.
SaleIndirect4.7K shares at avg. $6.02$28K - Sep 3, 2026ANTX
AN2 Therapeutics, Inc.
SaleIndirect3.2K shares at avg. $6.07$20K - Sep 3, 2026ANTX
AN2 Therapeutics, Inc.
SaleIndirect2.9K shares at avg. $6.07$17K - Aug 17, 2026ANTX
AN2 Therapeutics, Inc.
SaleIndirect16.7K shares at avg. $6.01$100K - Aug 17, 2026ANTX
AN2 Therapeutics, Inc.
SaleIndirect18.7K shares at avg. $6.01$112K - Mar 19, 2026ANTX
AN2 Therapeutics, Inc.
AwardDirectStock Option (right to buy)
20.7K shares- - Mar 19, 2026ANTX
AN2 Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
20.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 9, 2026 | ANTX AN2 Therapeutics, Inc. | Sale | 523 | $6.02 | $3,151 | Indirect |
| Sep 9, 2026 | ANTX AN2 Therapeutics, Inc. | Sale | 585 | $6.02 | $3,524 | Indirect |
| Sep 8, 2026 | ANTX AN2 Therapeutics, Inc. | Sale | 5,294 | $6.02 | $31,861 | Indirect |
| Sep 8, 2026 | ANTX AN2 Therapeutics, Inc. | Sale | 4,725 | $6.02 | $28,436 | Indirect |
| Sep 3, 2026 | ANTX AN2 Therapeutics, Inc. | Sale | 3,223 | $6.07 | $19,563 | Indirect |
| Sep 3, 2026 | ANTX AN2 Therapeutics, Inc. | Sale | 2,877 | $6.07 | $17,463 | Indirect |
| Aug 17, 2026 | ANTX AN2 Therapeutics, Inc. | Sale | 16,696 | $6.01 | $100,313 | Indirect |
| Aug 17, 2026 | ANTX AN2 Therapeutics, Inc. | Sale | 18,706 | $6.01 | $112,389 | Indirect |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc. | Award Stock Option (right to buy) | 20,724 | - | - | Direct |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc. | Disposition Stock Option (right to buy) | 20,724 | - | - | Direct |
1-10 of 29 transactions